Gencell Ltd

Tel Aviv Stock Exchange GNCL.TA

Gencell Ltd Revenue for the year ending December 31, 2023: USD 4.86 M

Gencell Ltd Revenue is USD 4.86 M for the year ending December 31, 2023, a -34.30% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Gencell Ltd Revenue for the year ending December 31, 2022 was USD 7.40 M, a 33.58% change year over year.
  • Gencell Ltd Revenue for the year ending December 31, 2021 was USD 5.54 M, a 1,610.49% change year over year.
  • Gencell Ltd Revenue for the year ending December 31, 2020 was USD 324.00 K, a -72.61% change year over year.
  • Gencell Ltd Revenue for the year ending December 31, 2019 was USD 1.18 M, a -47.65% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Tel Aviv Stock Exchange: GNCL.TA

Gencell Ltd

CEO Mr. Rami Reshef
IPO Date Nov. 24, 2020
Location Israel
Headquarters 7 Hatnufa Street
Employees 125
Sector Utilities
Industries
Description

GenCell Ltd. engages in the development and production of fuel cell-based energy systems. It offers GenCell BOX, a long-duration backup power solution that provides source of 5kW backup power for telecom and critical communications applications; GenCell REX, a utility backup power solution that produces 5kW of emission-free electricity for substations during power outages; and GenCell FOX, an off-grid power solution for telecom, schools, homes, hospital, border protection, CCTV, water purification and pumps, and heating. The company also provides GENCELL EVOX, a grid independent EV charging station; and GenCell IoT Remote Manager, a backup power solution for utilities, telecom, homeland security, healthcare, and other industrial applications. It operates in Israel, Mexico, the United States, Romania, Germany, Italy, and Canada. GenCell Ltd. was incorporated in 2011 and is headquartered in Petah Tikva, Israel.

StockViz Staff

January 15, 2025

Any question? Send us an email